We tested the activities of anidulafungin and other antifungal agents against clinical isolates of different fungal species. For Candida species, high sessile MIC 90 s (SMIC 90 s) were obtained for fluconazole, voriconazole, and amphotericin B, whereas the anidulafungin SMIC 90 s were very low, as were those for caspofungin. Comparatively, for Aspergillus species, higher SMIC 90 values were obtained not only for amphotericin B and voriconazole but also for the echinocandins.
Treatment of invasive Candida infections is often complicated by the ability of Candida species to form biofilms that exhibit elevated intrinsic resistance to various antifungal agents, in particular azoles and polyenes. This antifungal resistance may contribute to the increased pathogenicity of Candida species (2, 7), as observed in catheter-associated bloodstream infections due to biofilm-forming isolates (26) . Thus, removal of intravascular devices is currently recommended for management of device-related Candida infections whenever practicable (13) . A recent study exploring the early transcriptional responses of mature Candida albicans biofilm exposed to various antifungal agents suggests that enhanced extracellularmatrix or beta-glucan synthesis during biofilm growth (18) might prevent fluconazole and amphotericin B from reaching biofilm cells, thus impairing their cell toxicity and the associated transcriptional responses (27) . As echinocandins are noncompetitive inhibitors of beta-glucan synthesis (20) , this may explain why the drugs have been shown to be effective against Candida biofilms (4, 8, 9, 11, 28) . In another study, liposomal formulation of amphotericin B was shown to eradicate C. albicans biofilm in a continuous catheter flow model, whereas fluconazole and caspofungin were less effective (24) .
Similar to Candida, filamentous molds such as Aspergillus fumigatus have been shown to be implicated in biofilm-associated infections (17, 22) . In vitro, A. fumigatus has the ability to form adherent multicellular communities that are resistant to the effects of antifungal drugs (15, 23) . Typical biofilm structures, consisting of fungal mycelium surrounded by an extracellular matrix composed of galactomannan, ␣-1,3-glucans, and melanin (3), were also observed in aspergilloma or during invasive aspergillosis (12) . Interestingly, Mowat et al. (16) showed a time-dependent decrease in efficacy for amphotericin B, voriconazole, and caspofungin as the complexity of the A. fumigatus hyphal structure increased, suggesting that the matrix material may play a role in impeding drug action. 10 Aspergillus terreus, and 10 Aspergillus niger) isolates that were obtained from patients hospitalized at our institution from January 2000 through July 2010. All of the Candida isolates were from blood cultures, including 42 from patients with central venous catheters (26) , whereas the Aspergillus isolates were from cultures of bronchoalveolar lavage fluid, sputum, skin, nasal, and tissue specimens. C. albicans SC5314 was used as a positive control (21) . Anidulafungin and voriconazole (Pfizer, Inc., New York, NY), amphotericin B and fluconazole (Sigma Aldrich, Milan, Italy), and caspofungin (Merck Research Laboratories, Rahway, NJ) were obtained as standard powders and prepared according to Clinical and Laboratory Standards Institute (CLSI) guidelines (5, 6) .
The MICs for planktonic cells were determined by broth microdilution using the standard CLSI M27-A3 and M38-A2 methods and defined as the lowest drug concentrations that caused either an approximately 50% (for azoles and [only for Candida isolates] echinocandins) or a 100% (for amphotericin B) growth inhibition compared with that of the drug-free growth control (5, 6) . For Aspergillus isolates, the minimum effective concentrations (MECs) for echinocandins were determined according to the CLSI M38-A2 document and defined as the lowest drug concentrations that led to the growth of small, rounded, compact hyphal forms compared to the hyphal growth seen in the drug-free growth control well (6) . The MICs and MECs were recorded after incubation for 24 to 48 h. The MICs for sessile (biofilm) cells (SMICs) were determined by a 96-well microtiter-based method as previously developed (21) . This technique is based on the reduction of 2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide (XTT) by metabolically active sessile cells to yield a water-soluble colored formazan product that can then be measured spectrophotometrically in a microtiter plate reader. Briefly, biofilm-containing wells were filled with RPMI 1640 containing doubling concentrations of the antifungal drugs, whereas untreated biofilm wells were filled with RPMI 1640 without drugs for 24 h. Negative-control wells (containing XTT only) were also included. From the resulting colorimetric readings, and after subtraction of the corresponding values for negative controls, the SMICs were calculated and expressed as the lowest drug concentrations at which a 50% decrease in absorbance was detected in comparison with the level for the biofilms formed in the absence of drug (21) . For Candida isolates, echinocandin MICs and SMICs were also determined in the presence of 50% serum, as described previously (19) .
The distributions of antifungal MICs and SMICs for the different Candida species are shown in Tables 1 to 3 and Tables  S1 and S2 in the supplemental material. The anidulafungin SMIC 90 s (g/ml) for the isolates of C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, and C. krusei were 0.125, 1, 0.06, 0.06, and 0.25, respectively. The caspofungin SMIC 90 s (g/ml) for the isolates of C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, and C. krusei were 0.5, 8, 1, 0.5, and 1, respectively. As shown in Table 2 , serum increased anidulafungin SMIC 90 s (g/ml) to 1, 16, 4, 2, and 8 and caspofungin SMIC 90 s (g/ml) to 8, Ͼ16, 8, 8, and Ͼ16 for the isolates of C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, and C. krusei, respectively. The amphotericin B SMIC 90 s (g/ml) for the isolates of C. albicans, C. parapsilosis, and C. krusei were Ͼ32, whereas those for the isolates of C. tropicalis and C. glabrata were 32 and 16, respectively. The fluconazole and voriconazole SMIC 90 s (g/ml) for isolates of all the species studied were Ͼ1,024 and Ͼ128, respectively. As expected, fluconazole and voriconazole were ineffective against biofilms of all five Candida species, with none of the isolates showing an azole SMIC of Ͻ128 g/ml. Despite SMIC 90 values nearing those of the azoles, the SMICs (g/ml) of amphotericin B ranged from 0.5 to Ͼ32 for isolates of C. albicans, C. parapsilosis, C. tropicalis, and C. glabrata and from 1 to Ͼ32 for isolates of C. krusei. As detailed in Table 3 , isolates from all Candida species were captured almost equally at the different SMIC values, except for 40 C. parapsilosis isolates, for which SMICs of 0.5 to 2 g/ml comprised the majority of them (28 isolates). Consistent with recent data reported by Choi et al. (4), we showed that amphotericin B was weakly effective against the biofilms of all five species. This was also in agreement with the previous observation by Kuhn et al. (11) of unique efficacy by lipid-formulated amphotericin B against biofilms of C. albicans and C. parapsilosis isolates (SMICs of 0.25 and 1 g/ml, respectively), while conventional amphotericin B failed to inhibit the same Candida strains when grown as biofilms (SMICs of 4 and 8 g/ml, respectively). In addition, the use of microtiter plates as the surface for biofilm 90 value differing from that reported by some investigators (25) . As shown, anidulafungin was the agent most active against sessile cells of isolates from all five Candida species. Caspofungin, the other echinocandin antifungal tested, was slightly less effective in this study. Interestingly, a prominent difference was noted between the SMIC 90 values for anidulafungin (1 g/ml) and caspofungin (8 g/ml) for C. parapsilosis isolates, whereas the planktonic MIC 90 s were 0.5 g/ml for both drugs. However, this difference disappeared in the presence of serum, where both drugs showed higher SMIC 90 (16 and Ͼ16 g/ml, respectively), since serum was shown to differentially reduce the antifungal efficacies of echinocandin drugs due to their extensive binding to serum proteins (19) .
Planktonic MIC 90 shifts were consistently observed for both anidulafungin (8 g/ml) and caspofungin (16 g/ml), reflecting their greater antifungal potencies in the absence of serum. By this test condition, 30 of 40 C. parapsilosis isolates were found to exhibit caspofungin SMICs of Ն2 g/ml. Consistent with these findings, studies by Khun et al. (11) on two biofilmassociated C. parapsilosis isolates, one (PA/71) from a sputum culture and the other (P92) from a blood culture, demonstrated that caspofungin inhibited only PA/71 (SMIC of 0.125 g/ml) while exhibiting a high SMIC (4 g/ml) for strain P92. On the other hand, sessile cells from 12 C. parapsilosis isolates studied by Choi et al. (4) were all less susceptible to caspofungin (SMIC range of 1 to Ͼ16 g/ml). Whether the behavior of C. parapsilosis biofilm (10) or the rate of drug diffusion through the biofilm (1), also linked to the echinocandin relative hydro- a Planktonic MICs were determined by the CLSI broth microdilution method, whereas biofilm SMICs were measured by the XTT reduction assay. a Planktonic MICs were determined by the CLSI broth microdilution method, whereas biofilm SMICs were measured by the XTT reduction assay.
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on October 31, 2017 by guest http://aac.asm.org/ phobicity, would account for the different activity displayed by both echinocandins in our study is not known. Also, novel biochemical and genetic mechanisms in biofilm formation might be responsible for the observed differences in echinocandin susceptibilities among different Candida species, as suggested by Choi et al. (4) . In contrast to previous biofilm studies mainly focusing on C. albicans and C. parapsilosis isolates (8, 9, 11, 25), our analysis addressing clinical isolates of C. krusei confirms and extends data on the potency of anidulafungin and, to a lesser extent, caspofungin (8, 9) against Candida biofilms. As almost all of the bloodstream isolates in our study had been conclusively associated with a device infection (26) , this strengthens the importance of our findings in the context of clinical treatment of biofilm-related candidiasis and warrants investigation on the use of anidulafungin as an antifungal catheter lock solution to prevent invasive Candida infection in high-risk patients. With regard to the Aspergillus species, our SMIC results paralleled but expanded those of the previous few investigations involving A. fumigatus, which until now was the only Aspergillus species studied concerning antifungal drug susceptibility under biofilm conditions (3, 15, 16, 23 ). Despite a highlevel activity profile for anidulafungin and caspofungin (MEC range of 0.03 to 0.06 g/ml) against planktonic Aspergillus species isolates, which confirmed earlier data (14), we noticed that A. fumigatus (and three other species) isolates exhibited elevated SMICs for anidulafungin (ranging from 8 to Ͼ16 g/ml, except for A. terreus isolates, whose SMICs were Ͼ16 g/ml) and caspofungin (ranging from 16 to Ͼ16 g/ml). Accordingly, Seidler et al. (23) found that the echinocandin (caspofungin and micafungin) MICs for the A. fumigatus strain ATCC 9197 embedded in biofilm were Ͼ8 g/ml, whereas higher caspofungin SMIC values (64 to 128 g/ml) were obtained for the A. fumigatus strain Af293 when grown at 24 h (as dense intertwined hyphae) (16) as well as for the five A. fumigatus strains, including four clinical isolates studied by Mowat et al. (15) . In contrast (and in comparison with voriconazole [SMICs ranging from 32 to Ͼ128 g/ml]), amphotericin B was the most effective antifungal agent, as SMICs (g/ml) of 8 were found for eight isolates of A. fumigatus and A. flavus and SMICs of Յ8 were found for nine isolates of A. niger. Although expected, our SMIC data suggest a poor utility of these agents a Planktonic MECs were determined by the CLSI broth microdilution method, whereas biofilm SMICs were measured by the XTT reduction assay. 
